$124.6 billion Mandatory Provident Fund says virus ‘has affected the investment market worldwide.’
His 13.4% yearly corporate profit increase, admittedly over just three years, is bested only by Obama’s 26% over eight, CFRA’s Stovall finds.
Pummeled shares will take a lot longer to recover than normal, Allianz economist says.
Earnings growth is threatened by the epidemic, which has shut down much of China’s economy, strategist says.
AQR co-founder had called for adding more low-priced stocks, figuring their bad times had ended. Oops.
The effect of the outbreak has been ‘exaggerated,’ hedge fund honcho declares.
Hedge fund kahuna laments that markets aren’t prepared for a return bout of soaring prices.
GMO co-founder, a climate change activist, compares their paltry returns to the S&P 500’s tripling over 10 years.
The tempo of cap ex should slow to just 1% growth in 2020, the Conference Board predicts.
The coronavirus may be the disastrous surprise that overwhelms public health officials and slams the markets, the firm's Lonski admonishes.
While small names have done OK, they suffer from factors like a possibly weakening dollar, the firm’s John Lynch argues.
The alternative asset class investor is said to be gearing up for an upcoming public offering.
Thriving economy and trade war pause aid carriers, despite loss of tainted plane.
Market once more is shocked that this fraught diplomatic cage fight is far from over.